Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02136199 · ClinicalTrials.gov registry record · NA

Use of Decision Aids in Clinical Encounters

A NA study of Diabetes, Depression, Cardiovascular Disease,Hypercholesterolemia, Osteoporosis, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
62
Enrollment target
12
Study locations

NCT02136199: Completed NA study of Diabetes, Depression, Cardiovascular Disease,Hypercholesterolemia, Osteoporosis, sponsored by Mayo Clinic.

NCT02136199 is a NA study of Diabetes, Depression, Cardiovascular Disease,Hypercholesterolemia, Osteoporosis that has completed, run by Mayo Clinic. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 12 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02136199, a NA study of Diabetes, Depression, Cardiovascular Disease,Hypercholesterolemia, Osteoporosis, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
62 participants
Enrollment target
12
Study locations

Study Summary

The active strategy for dissemination and implementation of Share Evidence Based Medicine (EBM) will yield greater reach of clinicians, be adopted by the practices more readily, and a greater uptake of use amongst encounters will be seen. The Institute for Clinical Systems Improvement (ICSI) is a nonprofit organization with expertise in large-scale practice improvement at the state and national level. Largely funded by health organizations in Minnesota, ICSI has a sustainable model to translate evidence into practice, through clinical practice guidelines, shared decision making, and practice redesign. A partnership between these two organizations (ICSI and Mayo Clinic) may lead to a sustainable and innovative approach to the dissemination of evidence-based health information at the point of care. The objective of the current study is therefore to leverage the expertise of these two organizations to compare the impact of an active to a passive dissemination and implementation strategy of the ShareEBM toolkit. The aim of the study is to disseminate evidence-based information through the use of decision aids during encounters. The overall purpose of the qualitative evaluation is to understand why decision aids were used more or less in certain practices and what factors contributed to or hindered this uptake.

Interventions

  • OTHER Active Implementation of ShareEBM Toolkit
  • OTHER Passive Dissemination of Share EBM

Study Locations (12)

Minnesota

  • Park Nicollet- Brookdale - Brooklyn Center
  • Ridgeview Medical Center - Delano
  • Essentia Health-Lakeside Clinic - Duluth
  • Fairview Clinic-Eagan - Eagan
  • Park Nicollet-Golden Valley - Golden Valley
  • Essentia Hermantown Clinic - Hermantown
  • Native American Community Clinic - Minneapolis
  • Community Health Service, Inc. - Rochester
  • Mayo Clinic - Rochester
  • Fairview Medical-Rosemount - Rosemount

Wisconsin

  • Baldwin Area Medical Center, Inc. - Baldwin
  • Hudson Physicians S.C. - Hudson

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2014-09
Est. Completion 2016-05
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02136199 record still lists

NCT02136199 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Diabetes, Depression, Cardiovascular Disease,Hypercholesterolemia, Osteoporosis appearing as the primary indexed condition, and to 2 interventions - of which Active Implementation of ShareEBM Toolkit is the first listed.

NCT02136199 lists 12 locations in 2 states (Minnesota, Wisconsin).

Frequently Asked Questions

What is clinical trial NCT02136199 about?

NCT02136199 is a clinical study titled "Use of Decision Aids in Clinical Encounters". The active strategy for dissemination and implementation of Share Evidence Based Medicine (EBM) will yield greater reach of clinicians, be adopted by the practices more readily, and a greater uptake of use amongst encounters will be seen. The Institute for Clinical Systems Improvement (ICSI) is a n...

What is the current status of trial NCT02136199?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2014-09. Estimated completion is 2016-05.

What conditions does trial NCT02136199 study?

This clinical trial studies the following conditions: Diabetes, Depression, Cardiovascular Disease,Hypercholesterolemia, Osteoporosis.

What interventions are being tested in trial NCT02136199?

The interventions under investigation include: Active Implementation of ShareEBM Toolkit (OTHER), Passive Dissemination of Share EBM (OTHER).

Who is sponsoring clinical trial NCT02136199?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02136199 being conducted?

This trial has 12 study locations across Minnesota, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02136199's enrollment target sits among peer trials

62 1157th of 2000 higher than 837 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02136199, the US trial registry maintained by the National Library of Medicine. NCT02136199 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.